Diamond Biofund Inc (鑽石生技), the nation’s largest investment fund focusing on the biomedical industry, is seeking global investment funds to increase its capital to NT$10 billion (US$333.55 million) from NT$8 billion by the end of this year.
The venture capital firm hopes the extra cash will help it find good investment targets in the biomedical sector, an executive said yesterday at an investment forum in Taipei.
“The energetic biotechnology industry in Taiwan indicates that the nation not only has the ability to make academic breakthroughs, but also to commercialize the results — which surprises foreign investors,” Diamond Biofund vice president Winston Town (湯竣鈞) said at the forum, which was organized with the government-funded Institute for Biotechnology and Medicine Industry (IBMI).
Morgan Stanley Asia, McKinsey and Co, China-based CITIC Private Equity Funds Management Co (中信產業基金) and Credit Suisse Group AG also participated.
“They are all interested in the Taiwanese biotechnology industry and looking for possible investment targets,” IBMI chief executive Allen Wu (吳明發) said.
Established in 2011, Diamond Biofund has invested NT$1.8 billion, mostly in local companies. The market value of the invested firms’ shares that the venture capitalist purchased has increased to about NT$3.4 billion, based on current share prices, Town said.
Microbio Group (中天生技集團) is the fund’s largest investor, while Taishin Financial Holding Co (台新金控), Fubon Financial Holding Co (富邦金控) and Ruentex Industries Ltd (潤泰全球) have shares, he said.
Minister Without Portfolio Chiang Been-huang (蔣丙煌) said the nation has 26 biomedical firms on the Taiwan Stock Exchange and 57 in the over-the-counter GRETAI Securities Market, up from 30 in both two to three years ago.
There are 100 clinical trial projects in the nation, with about half under phase-two and phase-three trials, Chiang said.
The biotechnology industry has replaced the semiconductor and petrochemical industries to be the main target of the National Development Fund, Chiang said, which he said invested about NT$12.5 billion in the biomedical sector, in its NT$30 billion total investment.
Diamond Biofund and IBMI yesterday introduced 11 biomedical companies to investors, such as CHO Pharma Inc (醣基生醫), Crown Bioscience Inc (中美冠科生技), St Shine Optical Co (精華光學), Inno Pharmax Inc (因華生技), Original BioMedicals Co (原創生醫), Swissray Global Healthcare Holding (環瑞醫), Enimmune Corp (安特羅生技), Taiwan Advance Bio-Pharmaceutical Inc (台灣尖端先進), StemCyte Inc (永生生技) and Genomics BioSci & Tech Co (基龍米克斯).
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day